Bellicum pharmaceuticals licenses its caspacide safety switch to md anderson

Bellicum pharmaceuticals licenses its caspacide® safety switch to md anderson.bellicum pharmaceuticals inc - md anderson's decision to exercise option entitled bellicum to receive an upfront payment of $5 million.bellicum pharmaceuticals inc - upfront payment of $5 million will be recognized in q4 2019 results.
BLCM Ratings Summary
BLCM Quant Ranking